Navigation Links
Aptuit Names Jonathan Goldman As CEO
Date:12/2/2013

GREENWICH, Conn., Dec. 2, 2013 /PRNewswire/ -- Timothy C. Tyson, Chairman of Aptuit LLC, announced today the appointment of Jonathan Goldman, MD as Chief Executive Officer (CEO), completing the company's senior management leadership team.

(Logo: http://photos.prnewswire.com/prnh/20120217/NY55633LOGO)

Dr. Goldman will focus his efforts on the growth of Aptuit as a leading provider of outsourced services in the early development space by establishing new partnerships with clients and pursuing strategic acquisitions. He joins the company after achieving significant success at ICON Clinical Research, a leading global Contract Research Organization that specializes in the provision of clinical and other solutions that support Phase I-IV clinical studies.

Dr. Goldman stated, "I'm delighted to join Aptuit, and look forward to working closely with the entire team to leverage an outstanding value proposition that is unique in our industry. Pharma has an unmet need for lower cost, increased speed and better quality in drug discovery and development. Aptuit is the ideal partner to meet these needs across a comprehensive suite of services, supported by an approach that is both scientific and innovative. I look forward to continued growth of the company as the partner of choice for drug developers."

At ICON, Dr. Goldman was most recently Executive Vice President, Global Strategic and Business Development and a member of the senior leadership team. His accomplishments included record growth levels of sales, and the development of transformative business relationships with leading pharmaceutical and biotechnology companies. Previously, his roles at ICON included Executive Vice President, Operations, Strategic Programs and Chief Medical Officer, ICON Medical Imaging.

Before joining ICON, Dr. Goldman served for 7 years as the Chief Medical Officer of POINT Biomedical, a US-based biopharmaceutical company that discovered and developed microsphere technologies and drugs. In addition, he has held honorary academic positions of increasing responsibility at the University of California since 2000, most recently as Associate Clinical Professor of Medicine in the Division of Cardiology. He holds a medical degree from St. Bartholomew's Hospital Medical College, University of London, and MBA degrees from Columbia University in New York, and the University of California, Berkeley.

Mr. Tyson commented, "We're enthusiastic that Jonathan is joining us. He brings exceptional experience in science, sales and medicine, along with the innate talents that are needed to advance us to the next level of growth and accomplishments. His collaborative approach to understanding and satisfying the unmet needs of our clients makes him the perfect complement to our senior management team."

Stuart Needleman, Aptuit's President and Chief Operating Officer, added, "Over the past few years, we have achieved an impressive track record of success in delivering drug discovery and development results in multiple therapeutic areas. I am especially proud of recent results we have delivered, since they enabled our clients to succeed despite some very difficult circumstances. Aptuit continues to forge ahead on a serious path of aggressive growth, and Jonathan is an industry leader who can help us to get to the next level through his focus on top line opportunities."

For more information, please send an email to info@aptuit.com or contact Maria Garvey, Delfino Marketing at 914-747-1400 or maria@delfino.com.

Aptuit LLC provides the most complete set of integrated early to mid-phase drug development services in the pharmaceutical industry including Drug Design & Discovery, Preclinical Biosciences, API Development and Manufacture, Solid State Chemistry, and Pharmaceutical Sciences. The company maintains five global facilities with approximately 800 employees in Europe and the United States. Aptuit LLC is partnered with Welsh, Carson, Anderson & Stowe, one of the world's leading private equity investors.

For more information about Aptuit, visit www.aptuit.com


'/>"/>
SOURCE Aptuit
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aptuit Names Dr. Maurizio Denaro As General Manager In Verona, Italy
2. Aptuit and GSK Extend Strategic Partnership
3. Aptuit Drug Discovery & Development Center In Verona, Italy Hits 100th Client Milestone
4. 3-V Biosciences Names Dr. William McCulloch Chief Medical Officer
5. Seno Medical Instruments Names Dr. Thomas Stavros Medical Director
6. CVS Caremark Names Tracy Bahl as Executive Vice President, Health Plans
7. GrandCare Systems Names Daniel Maynard As New Chief Executive Officer
8. Catabasis Names Ian Sanderson Chief Financial Officer
9. Imprimis Pharmaceutical Names Seasoned Ophthalmology Executive John Saharek as Vice-President of Commercialization for its Ophthalmology Division
10. Accelerate Diagnostics, Inc. Names Mark C. Miller to Board of Directors
11. 2013 ISPE Facility of the Year Awards Program Names Novartiss United States Flu Cell Culture Facility as Overall Winner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... -- Research and Markets has announced the addition of ... to their offering. ... The global fluoropolymer market in the healthcare industry to grow ... Global Fluoropolymer Market in the Healthcare Industry 2016-2020, has been ... experts. The report covers the market landscape and its growth prospects ...
(Date:1/17/2017)... , Jan. 17, 2017 Following an ... today praised the Food and Drug Administration,s (FDA,s) ... Human Drug Products by Pharmacies and Outsourcing Facilities." ... proposed limitation on pre-packaging -- which would have ... costs to long term care (LTC) pharmacies.  ...
(Date:1/17/2017)... ReportsnReports.com adds "Anaphylaxis - Pipeline Review, H2 2016" ... Anaphylaxis,s therapeutic pipeline with comprehensive information on the therapeutic development ... assessment by drug target, mechanism of action (MoA), route of ... featured news and press releases. ... Complete report on H2 2016 pipeline ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... A prescription medication bottle, pocket knife, luggage ... Cradle to Cradle Product Design Challenge , the Cradle to Cradle Products Innovation ... circular design challenges scheduled to run through early 2018. The challenges are presented by ...
(Date:1/17/2017)... ... 2017 , ... SC&H Group, a leading audit, tax, and consulting firm, announced ... Advisory Services practice . Rossi is the third technology consulting leader to join SC&H ... grows, and the practice continues to expand.     , Bringing more than 25 years of ...
(Date:1/17/2017)... ... January 17, 2017 , ... The Sharie Withers ... has announced the latest beneficiary of their thriving community involvement program. The current ... to fulfilling the dreams of terminally ill patients. Donations to this worthy cause ...
(Date:1/17/2017)... Falls, NJ (PRWEB) , ... January 17, 2017 ... ... and Learning Center and the Montclair State University’s Athletic Training Education program forged ... State University’s Athletic Training Education Program, which is consists of both student ...
(Date:1/16/2017)... York, NY (PRWEB) , ... January 16, 2017 , ... ... grand opening of a new showroom in East Hanover, New Jersey. , “We are ... Gym Source. “The new innovative in-store concept is designed to give clients a seamless ...
Breaking Medicine News(10 mins):